Protective effects of Hawthorn (Crataegus oxyacantha) extract against digoxin-induced arrhythmias in rats
Hayrullah Alp1, Burak Cem Soner, Tamer Baysal
1Department of Pediatric Cardiology, Malatya State Hospital, Malatya-Turkey. drhayrullahalp@hotmail.com.
Insights
Crataegus oxyacantha extract demonstrated antiarrhythmic effects against digoxin-induced arrhythmias in rats. While effective, its potential hypotensive impact requires consideration for clinical use in treating digoxin toxicity.
Area of Science:
- Pharmacology
- Cardiovascular Research
- Herbal Medicine
Background:
- Digitalis preparations are vital for heart disease but carry risks of cardiac side effects with excessive doses.
- Understanding potential natural interventions for managing drug-induced arrhythmias is crucial.
Purpose of the Study:
- To investigate the antiarrhythmic efficacy of Crataegus oxyacantha extract against digoxin-induced arrhythmias.
- To evaluate the impact of the extract on electrocardiographic parameters and blood pressure in a rat model.
Main Methods:
- Anesthetized Wistar rats were divided into control and experimental groups.
- Digoxin was infused to induce arrhythmias, with Crataegus oxyacantha extract administered to the experimental group and saline to controls.
- Electrocardiographic QRS duration and arterial blood pressure were monitored.
Main Results:
- The Crataegus oxyacantha group exhibited increased survival time and reduced durations of atrial and ventricular arrhythmias.
- Significant bradycardia and prolonged QRS duration were observed in the control group.
- The experimental group showed a significant decrease in arterial blood pressure (hypotensive effect).
Conclusions:
- Crataegus oxyacantha alcoholic extract possesses antiarrhythmic properties against digoxin-induced arrhythmias in rats.
- The extract may serve as a potential alternative treatment for digoxin toxicity-related arrhythmias.
- The observed hypotensive effect necessitates careful consideration for clinical application.
Objective:
Digitalis preparations are commonly used by children and adults with heart diseases worldwide, although excessive doses may cause cardiac effects. The aim of the study is to evaluate the antiarrhythmic effect of Crataegus oxyacantha extract on digoxin-induced arrhythmias in anesthetized Wistar rats.
Methods:
Control and experimental groups were evaluated for arrhythmias induced by digoxin. Fifteen rats (7 as controls and 8 as the experimental group) were included in the study. The dry fruits of 100 mg Crataegus oxyacantha were extracted by percolation method. Digoxin, at a dose of 40 µg/kg/min, was infused to form the arrhythmias in all rats. Simultaneously, the extract was infused into the experimental group, while 0.9% NaCl was infused into control group. Electrocardiographic QRS prolongation and arterial blood pressure changes were analyzed.
Results:
The experimental group lived longer (62.13±2.20 min) than the controls (p=0.002). On the other hand, the time to beginning of QRS prolongation did not differ between the two groups (p=0.812). Bradycardia was significant in the control group (288.01±10.54 beat/min and p=0.01). The maximum QRS duration was observed in the control group during the digoxin and 0.9% NaCl infusion period (53.29±3.99 ms and p=0.001). Also, the durations of atrial and ventricular arrhythmias were shorter in the experimental group. However, arterial blood pressure dipping was significant in the experimental group (23.67±10.89 mm Hg and p<0.001).
Conclusion:
Crataegus oxyacantha alcoholic extract produced an antiarrhythmic effect that was induced by digoxin in Wistar rats. However, in the clinical use of this extract, the hypotensive effect should be considered. Also, the alcoholic extract of Crataegus oxyacantha may be an alternative treatment medication for arrhythmias induced by digoxin toxicity in humans.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Dysrhythmias VI: Management of Dysrhythmias


